Endeavoring in Consumer Business

Consumer biz

We provide products and services essential to our customers' daily lives.

Health Care

We develop NDI and fucntional health food/supplements that enhance immune function, offering effective immune-boosting solutions.

Skin Care

We aim to create innovative solutions for skin health by developing cosmeceutical products with GPGA Complex as a key ingredient.

Pet Care

We offer groundbreaking solutions to protect pet health and improve the quality of life for pets and their owners.

Tailored Healthcare solution

We develop customized solutions for immunity enhancement, skin rejuvenation, and pet healthcare,
and pet healthcare, providing innovative products that help people and pets achieve optimal health and happiness based on their needs.
All products are based on clinical research and thorough verification, and we do our best to meet our customers' diverse needs and expectations.

Endeavoring in pharmaceutical/non-pharmaceutical business

Pharma Biz

We provide products and services essential to our customers' daily lives.

More Business

Vaccine Creation

Moalifeplus is committed to researching and developing safe and effective vaccines to prevent specific diseases, empowering individuals to lead healthier lives.

Therapy Development

Moalifeplus is focused on researching and developing safe and effective treatments to cure diseases and alleviate symptoms, enabling patients to lead better lives.

Development of integrated prevention and treatment solutions

Moalifeplus is dedicated to enhancing the health and quality of life of our customers through innovative medicine development and supply.
We deliver safe, reliable treatments via rigorous quality control and a patient-centric approach, offering solutions for diverse medical conditions3.
Our ongoing investments in global partnerships and R&D aim to expand medicine accessibility and contribute to a healthier society

Innovative Biomarker

Moalife Plus is dedicated to innovative research that enhances skin health through the development of new materials focused on anti-aging, restoration, and regeneration functions.

Skin Biotechnolgy

Moalifeplus focuses on innovative research for skin health enhancement using novel materials with skin anti-aging, restoration, and regeneration properties

Platform technology

Our technology aims to induce immune responses

against specific diseases

through antigen delivery using probiotics,

and to enhance overall immunity by activating immune cells with γ-PGA from Bacillus subtilis.

These technologies play a crucial role in stimulating the immune system to protect against diseases.

Purified natural amino acid polymer

Core technology using γ-PGA to enhance natural killer cell activity by stimulating mucosal immune cells.

Natural substances derived from fermented foods

A natural substance found in fermented soybean foods, like our unique 'Cheonggukjang,' is an edible amino acid polymer.

Enhanced immune response yields anticancer and anti-inflammatory benefits.

Effective against cancer, antiviral, and inflammatory diseases due to increased immune response by poly-gamma-glutamic acid

Pipeline

Moalifeplus is an innovative company focused on developing biopharmaceuticals,

including cancer treatments, immunotherapies, and vaccines for infectious diseases.

Our pipeline products are actively researched in preclinical

and clinical stages, aiming to verify their safety and efficacy for global market launch.

Moalifeplus strives to provide patients with new treatment options

and play a leading role in the global healthcare market.

Reasons for p53 reactivation

Addressing cellular proliferation and carcinogenesis is key to developing innovative, life-saving cancer treatment.

Cervical cancer treatment vaccine clinical phase 2b

The Phase 2b clinical trial for BioLeaders' drug, conducted at 16 institutions since August 2017, aims to demonstrate its efficacy and confirm the statistical significance of the Phase 1/2a treatment effect.

BLS-H03

γ-PGA enhances vaccine antigenicity and immune durability, providing safe viral protection with lower antigen doses and minimal side effects.

Research Paper & Patent

Moalifeplus has achieved innovative results in biopharmaceutical research and development,

holding numerous publications and patents.

Our research team has published various scientific papers based on significant discoveries

and secured patents in multiple countries using proprietary technology,protecting Moalifeplus's achievements.

Through these efforts, we aim to maintain a leading role in the global healthcare market.

The company has obtained 56 international patents, 31 domestic patents, totaling 88 patents4.

Cervical Precancer (M.MucoMax®)

We've secured patent registrations in 17 countries for our stable, high-expression vectors used in cervical cancer treatment vaccines and human papillomavirus vaccines, as well as for the recombinant lactic acid bacteria and microorganisms utilizing these vectors.

Muscular Dystrophy (M.MucoMax®)

Patents for vectors expressing Myo-2 peptide polymer and myostatin fusion proteins on cell surfaces, transformed microorganisms, and myostatin-expressing cell surface vectors have been completed and registered in six countries.

BLS-H03 (H.HumaMax®)

We have completed patent registration for an immunoadjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles and a vaccine containing poly-gamma-glutamic acid-chitosan-sM2HA2 nanoparticles or poly-gamma-glutamic acid-chitosan-sM2HA2CTA1 nanoparticles, and they have been registered in 4 countries.

Enhancing Life

and Health

through Innovation

and Trust

Moalifeplus values life and the bond with companion animals,

contributing to health improvement through innovative pharmaceutical development.

Our goal is to not only maintain health but also enhance quality of life and secure a better future for all. Moa Life Plus will continue to grow as a global healthcare leader, advancing respect for life and quality of life through ongoing research and development.

우리의 목표는 단순히 건강을 유지하는 것을 넘어서, 삶의 질을 높이고, 모든 이들에게 더 나은 미래를 제공하는 것입니다. 모아라이프플러스는 앞으로도 지속적인 연구와 개발을 통해 생명 존중과 삶의 질 향상에 기여하며, 글로벌 헬스케어의 리더로서 끊임없이 성장해 나갈 것입니다.

H e a l t h i n E v e r y

M o m e n t

A commitment to good health, Add health to your daily life

Platform technology

Pipeline

Research Paper & Patent

Enhancing Life

and Health

through Innovation

and Trust

Moalifeplus values life and the bond with companion animals,

contributing to health improvement through innovative pharmaceutical development.

면역엔 피지에이케이(PGA-K)

면역88 골드 PGA-K

면역88 키즈

유브잇 UV-EAT

닥터스피지에이 딥 케어 모이스처라이징 크림 밀당크림 50ml

닥터스피지에이 스페셜 케어 UV 프로텍팅 선스크린 50g

모아라이프플러스, 상장 이후 분기 실적 최초 흑자 달성

모아라이프플러스, 동남아 화장품 수출 판로 넓힌다

모아라이프플러스, 말레이시아와 제품 공급계약 체결

모아라이프플러스, R&D성과에 유동성도 장전…경영정상화 '돌입'

모아라이프플러스, 美 기업에 근육질환 치료물질 기술 이전

1600억원 투자 협약 보도자료는 당사와 관계없는 사항입니다.

[단독]비엘, 근감소증 치료제 북미 4개 회사와 기술수출 협상중

비엘그룹 성장 키워드 '해외사업·유통채널 다변화'

H e a l t h i n E v e r y M o m e n t A commitment to good health, Add health to your daily life

Platform technology

Pipeline

Research Paper & Patent

Enhancing Life

and Health

through Innovation

and Trust

Moalifeplus values life and the bond with companion animals,

contributing to health improvement through innovative pharmaceutical development.

면역엔 피지에이케이(PGA-K)

면역88 골드 PGA-K

면역88 키즈

유브잇 UV-EAT

닥터스피지에이 딥 케어 모이스처라이징 크림 밀당크림 50ml

닥터스피지에이 스페셜 케어 UV 프로텍팅 선스크린 50g

모아라이프플러스, 상장 이후 분기 실적 최초 흑자 달성

모아라이프플러스, 동남아 화장품 수출 판로 넓힌다

모아라이프플러스, 말레이시아와 제품 공급계약 체결

모아라이프플러스, R&D성과에 유동성도 장전…경영정상화 '돌입'

모아라이프플러스, 美 기업에 근육질환 치료물질 기술 이전

1600억원 투자 협약 보도자료는 당사와 관계없는 사항입니다.

[단독]비엘, 근감소증 치료제 북미 4개 회사와 기술수출 협상중

비엘그룹 성장 키워드 '해외사업·유통채널 다변화'

H e a l t h i n E v e r y

M o m e n t

A commitment to good health, Add health to your daily life